Novo Nordisk A/S Sponsored ADR Class B (NVO) is currently at $52.73, up $4.63 or 9.63%
--Would be highest close since Oct. 27, 2025, when it closed at $52.89
--On pace for largest percent increase since Aug. 8, 2023, when it rose 17.23%
--Currently up three consecutive days; up 10.75% over this period
--Best three-day stretch since the three days ending Sept. 18, 2025, when it rose 11.2%
--Up 6.85% month-to-date; on pace for best month since Aug. 2025, when it rose 19.95%
--Down 38.7% year-to-date; on pace for worst year since 1984, when it fell 57.59%
--Down 64.11% from its all-time closing high of $146.91 on June 25, 2024
--Down 39.65% from 52 weeks ago (Dec. 24, 2024), when it closed at $87.37
--Down 42.02% from its 52-week closing high of $90.95 on Feb. 25, 2025
--Up 17.26% from its 52-week closing low of $44.97 on Nov. 24, 2025
--Traded as high as $53.20; highest intraday level since Oct. 27, 2025, when it hit $53.22
--Up 10.6% at today's intraday high; largest intraday percent increase since Jan. 24, 2025, when it rose as much as 10.94%
All data as of 9:55:09 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
December 23, 2025 10:03 ET (15:03 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments